we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
So how do we engage or revamp our primary care workforce to include more obesity training for primary care physicians to really manage this population? A drug by any other name Semaglutide , one of the top-selling drugs in the United States in 2024, is marketed as Wegovy for weight management, as Rybelsus in an oral formulation for managing Type 2 diabetes and as Ozempic for treating Type 2 diabetes, reducing cardiovascular risk in patients with Type 2 diabetes and reducing the risk of kidney disease worsening in adults with Type 2 diabetes and chronic kidney disease
Common effects include: Nausea Constipation Vomiting Diarrhea Bloating Reduced appetite Less common but serious risks may include: Gallbladder disease Pancreatitis Severe dehydration Patients with certain thyroid cancer histories may not be appropriate candidates for some GLP-1 medications
The side effects are its biggest limitation
If you have questions about weight loss, your Baptist Health bariatric care provider can help
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)